Corrigendum to & lt;'Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials' & gt;[J Microbiol Immunol Infect 55 (1) (2022) 26-35]

J Microbiol Immunol Infect. 2023 Oct 17:S1684-1182(23)00194-9. doi: 10.1016/j.jmii.2023.10.003. Online ahead of print.NO ABSTRACTPMID:37858516 | DOI:10.1016/j.jmii.2023.10.003

Source: Journal of Microbiology, Immunology, and Infection - October 20, 2023 Category: Microbiology Authors: Shao-Huan Lan Chih-Cheng Lai Shen-Peng Chang Chun-Chun Hsu Cheng-Hsin Chen Ya-Hui Wang Yueh Lan Huang Cheng-Yi Wang You-Shuei Lin Source Type: research